Navigation Links
Mylan Announces Pricing of $2.0 Billion of Senior Notes
Date:11/19/2013

PITTSBURGH, Nov. 19, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced the pricing of a registered offering of aggregate principal amount of $2.0 billion in bond issuance comprised of: 

  • $500 million aggregate principal amount of 1.35% Senior Notes due 2016;
  • $500 million aggregate principal amount of 2.55% Senior Notes due 2019; 
  • $500 million aggregate principal amount of 4.20% Senior Notes due 2023; and
  • $500 million aggregate principal amount of 5.40% Senior Notes due 2043.

Mylan intends to use the net proceeds from the offering to fund the previously announced acquisition of the Agila Specialties business of Strides Arcolab (the "Agila Acquisition") and for general corporate purposes, including, but not limited to, repayment of short-term borrowings which may include repayment of borrowings under its revolving credit facility and accounts receivable securitization facility, and funding a previously announced buyback of our common stock of up to $500 million. Subject to customary closing conditions, the sale of the notes is expected to close on or about Nov. 29, 2013. Mylan continues to anticipate that it will complete the Agila Acquisition in the fourth quarter of 2013.

The offering may be made only by means of a prospectus supplement and a prospectus. A copy of the prospectus supplement and the prospectus relating to the offering will be filed with the Securities and Exchange Commission (the "SEC") and, when available, can be obtained from: (i) Merrill Lynch, Pierce, Fenner & Smith Incorporated at 222 Broadway, 11th Floor, New York, NY 10038, Attn: Prospectus Department, toll free at +1-800-294-1322 or at dg.prospectus
'/>"/>

SOURCE Mylan Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Mylan Applauds New Federal Legislation to Increase Anaphylaxis Preparedness in Schools
2. Mylan to Present at the 2013 Credit Suisse Healthcare Conference
3. Mylan Reports Third Quarter 2013 Adjusted Diluted EPS of $0.82
4. Mylan Supports Generic Drug Industrys Call on FDA to Uphold Consistent, Proven International Standard for Biosimilar Naming
5. Mylan to Speak at the Morgan Stanley Global Healthcare Unplugged Conference
6. Mylan to Speak at the Bank of America Merrill Lynch Global Healthcare Conference
7. Mylan Announces Completion of Transdermal Patch Facility Expansion Project in St. Albans, Vt.
8. Mylan Acquisition of Agila Receives Approval from Indias Foreign Investment Promotion Board and Cabinet Committee on Economic Affairs
9. Mylan Confirms Approval of sANDA for Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg
10. Mylan Reports a 13% Increase in Second Quarter 2013 Adjusted Diluted EPS to $0.68
11. Third Circuit Rules in Mylans Favor Regarding Paroxetine Hydrochloride Extended-Release Tablets, Sending Mylans Breach of Contract Claim Against GSK to Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 2014 Nanomix Inc., (Nanomix), a ... of mobile diagnostic tests to enable earlier ... pre-hospital settings, today announced it has received ... certification was awarded by the British Standards ... certification bodies. ISO 13485:2003 ...
(Date:11/26/2014)... 2014  Breckenridge Pharmaceutical, Inc. announced today that ... with Pii (Pharmaceutics International, Inc.) ( Hunt ... Pii expect to develop and commercialize several new ... will develop, manufacture and supply the products, and ... its own label.  The drugs, comprised of four ...
(Date:11/26/2014)... , Nov. 25, 2014 Halozyme Therapeutics, Inc. (NASDAQ: ... Jaffray Healthcare Conference in New York ... PDT . Dr. Helen Torley , President and ... The presentation will be webcast through the "Investors" section of ... will be made available for 90 days following the event. ...
Breaking Medicine Technology:Nanomix Receives ISO 13485:2003 Certification 2Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc. 2Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2
... , RIVIERA BEACH, Fla., Dec. 14 Perry Baromedical, international ... launch of the Sigma Elite, with extended patient data capture ... on each monoplace chamber model currently available ( www.perrybaromedical.com ) ... "Smart Hyperbaric System" includes: , Data Capture Via Computerized ...
... Dec. 14 Sword Diagnostics, Inc. is pleased to ... has issued patent number 7,599,057 titled "Method and Apparatus ... the company. The patent covers the core technology which ... this patent supports the underlying strategy as we move ...
Cached Medicine Technology:Perry Baromedical Announces New Cutting Edge Technology With Patient Data Capture Capability 2
(Date:11/27/2014)... DressVe , the well-known trendy young women’s clothing retailer, has ... Nov. 29 – Dec. 3 2014. In the special offer, ... 90% off. In addition, free delivery is provided for the ... , Dresses that combine trendy styles and high quality ... and figure. The designers of DressVe.com know this point very ...
(Date:11/27/2014)... This is a professional and in-depth study on ... a focus on the Chinese market. The report provides ... manufacturers and is a valuable source of guidance and ... , Firstly, the report provides a basic overview of ... Then, the report explores the international and Chinese major ...
(Date:11/27/2014)... November 28, 2014 The American Society for ... social media campaign in honor of World AIDS Day 2014. ... tested. Find a cure.” icon and infographic designed to generate ... getting tested for HIV. , ASCP has asked members to ... “Give a minute. Get Tested. Find a cure.” icon and ...
(Date:11/27/2014)... 27, 2014 According to a recent ... looking to break into the surgical robotics market ... other than the MIS field dominated by Intuitive. These ... U.S. surgical robotics market by 2020. , “The ... Kamran Zamanian, CEO and President of iData. “System sales ...
(Date:11/27/2014)... 2014 In a world enveloped ... sleep has lessened, and due to the intrusion ... of sleep has eroded. According to Web MD, ... job (Reference: http://www.webmd.com/sleep-disorders/features/sleep-deprivation-workplace ). This remarkably high ... an incalculable amount, leading not only to dissatisfied ...
Breaking Medicine News(10 mins):Health News:DressVe.com Introduces Its 2014 Special Monday Sales To The Global Customers 2Health News:Bronchoscopes Industry 2019 Forecasts for Global and China Region in New Research Report at ReportsnReports.com 2Health News:Bronchoscopes Industry 2019 Forecasts for Global and China Region in New Research Report at ReportsnReports.com 3Health News:ASCP Launches Social Media Campaign in Honor of World AIDS Day 2Health News:U.S. Robotic Surgery Market Set to Diversify and Grow: Intuitive Surgical’s ‘da Vinci’ Robot Revenues to Increasingly Rely On Procedures and Services 2Health News:Research Shows Surprising Number of US Workers Affected by Lack of Sleep 2
... of people are disappointed that the condom has not served ... sex, which defeats the goal of using condoms. ... for the FPA, Family Planning association, and the findings revealed ... reasons for ineffective use of condoms. As much as 43% ...
... the US U.S. doctors often misdiagnose tuberculosis due to ... suffer for years.// ,Tuberculosis is among the ... to the World Health Organization, has taken the lives ... tuberculosis bacterium has the ability to remain dormant for ...
... air sterilization technology that the U.S. Department of Defense ... may be protecting hospital patients from deadly infections, thanks ... of Science, Technology and Academic Research (NYSTAR). ,The ... becoming increasingly difficult to treat, are on the rise. ...
... known; a bite on the body that allows the virus ... happens next that causes the virus //to multiply and take ... Medical Institute (HHMI) international scholar in Argentina have been able ... virus multiply, which is the main cause of the potentially ...
... by the stem cells researchers across the world and ... Illumina Inc., it was found that embryonic stem cell ... totipotent. ,This sets aside the embryonic stem ... These characteristics could be later used to replace diseased ...
... Treatment Trial (NETT) it was found that emphysema patients ... ,The bilateral lung volume reduction surgery (LVRS) to ... among these patients. NETT researchers describe the effects of ... 4.3 years, two years longer than the primary results ...
Cached Medicine News:Health News:Doctors In US Lack Skills For The Diagnosis Of TB 2Health News:Device Can "Battle" Hospital Infections 2Health News:Device Can "Battle" Hospital Infections 3Health News:The Dengue Virus Unplugged 2Health News:The Dengue Virus Unplugged 3Health News:Human Embryonic Stem Cells Could Be Later Used In Therapeutic Cloning 2
The K-ASSAY Anti-Streptolysin O Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assay for quantifyi...
Eppendorf expands its line of benchtop microcentrifuges with the 5418. This easy-to-use microcentrifuge features a certified aerosol-tight rotor and a unique, contoured rotor bowl design to reduce no...
... The Directigen EZ Flu A+B test ... direct and qualitative detection of influenza A ... and throat swabs of symptomatic patients. The ... differentiated test, such that influenza A viral ...
... Mid-Urethral Sling System is intended to ... sling for the treatment of stress ... an innovative mid-urethral sling that offers ... all of which are designed to ...
Medicine Products: